Latest News and Press Releases
Want to stay updated on the latest news?
-
La OneSight EssilorLuxottica Foundation firma un accordo di collaborazione con l’Organizzazione Mondiale della Sanità nell’ambito dell’iniziativa SPECS 2030, per promuovere la cura della vista a...
-
OneSight EssilorLuxottica Foundation se une a la Organización Mundial de la Salud para impulsar los cuidados globales de la visión bajo la iniciativa SPECS 2030 de la OMS Paris, Francia, 6...
-
OneSight EssilorLuxottica Foundation Joins Forces with World Health Organization to Advance Global Vision Care Under WHO SPECS 2030 Initiative Paris, France and Geneva, Switzerland (6 December 2024)...
-
Claremont, CA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Keck Graduate Institute (KGI), a member of The Claremont Colleges and a pioneering graduate school focused on educating tomorrow's biotech and...
-
ANN ARBOR, Mich., Sept. 13, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
-
ANN ARBOR, Mich., Sept. 10, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
-
Non-diffractive IOLs SERENITY and SERENITY Toric are the second generation of BVI’s original, innovative ISOPURE premium monofocal IOL launched in 2019.These IOLs incorporate patented ISOFOCAL optic...
-
OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease
LONDON and NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
-
Austin, TX, USA, July 31, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “US Eyewear Market Size, Trends and Insights By Product Type (Prescription...
-
Cepham announces the launch of Luteye to combat the effects of aging on eyes.